Navigation Links
Availity Teams with Thomson Reuters to Integrate Treatment Cost Calculator
Date:6/1/2009

Solution to Help More Health Plans Deliver Price Transparency

JACKSONVILLE, Fla., June 1 /PRNewswire/ -- Availity, LLC, the industry's premier health information network, today announced an agreement with Thomson Reuters to integrate its Treatment Cost Calculator into Availity's financial estimation solution, CareCost Estimator(SM). Through this agreement, Availity will offer health plan customers additional tools to derive cost estimates for delivery to providers through CareCost Estimator.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080715/CLTU028LOGO )

Health plans that support CareCost Estimator today calculate treatment estimates using their internal systems and deliver the information to Availity to display to the provider in real-time. This gives providers the information they need to collect the patient's financial responsibility at the point of care, helping to improve the practice's cash flow and accounts receivable. The integration of the Cost Calculator helps Availity respond to those health plans that need solutions for generating the treatment estimates.

"Patients need accurate, customized cost estimates to make informed decisions about their care," said Russ Thomas, president and chief operating officer for Availity. "Working with Thomson Reuters is another step Availity is taking to advance cost transparency and improve provider and patient satisfaction."

"We are delighted to work with Availity to help advance transparency in health care," said David Crean, senior vice president for the Health Care and Science business at Thomson Reuters. "Integrating the Treatment Cost Calculator within the Availity portal and the provider workflow helps to further our shared mission of delivering reliable health information in real-time."

About Availity, LLC - Patients. Not Paperwork.(R)

Availity optimizes information exchange between multiple health care stakeholders through a single, secure network. The Availity Health Information Network encompasses administrative, financial, and clinical services, supporting both real-time and batch exchange via the web, business to business (B2B) integration, and electronic data interchange (EDI). For more information, including an online demonstration, please visit www.availity.com.

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance and enhance the quality of healthcare. Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. Thomson Reuters shares are listed on the New York Stock Exchange (NYSE: TRI); Toronto Stock Exchange (TSX: TRI); London Stock Exchange (LSE: TRIL); and Nasdaq (Nasdaq: TRIN). For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Availity, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Availity Engages Prematics to Deploy Electronic Prescribing
2. Availity Engages Prematics to Deploy Electronic Prescribing Solution
3. Availity Awarded Full EHNAC Accreditation
4. Availity Achieves 2008 eHealthcare Leadership Award
5. Availity Achieves Excellence in Blended Learning Award
6. Availity Enables Real-Time Electronic TRICARE Transactions with Humana Military Healthcare Services in Three Southern States
7. Availity Partners With MedEZ
8. Availity Offers No Cost Florida Medicaid Transactions to Providers
9. Availity Announces Support of Project SwipeIT
10. Availity Promotes Russ Thomas to President and Chief Operating Officer
11. WellPoint Announces Strategic Relationship With Availity to Enhance the Provider and Health Plan Relationship and Advance Improvements in Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... Delta ... $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired as ... was the American Cancer Society’s 2015 CEO of the Year , helped lead ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Discover the ... visit over 1,400 booths and 700 companies. Attendees also get to see the ... Colorado Garden & Home Show , at the Colorado Convention Center - 700 ...
(Date:2/8/2016)... ... 08, 2016 , ... Guruji Mahendra Kumar Trivedi is offering 3 days of ... of his birthday on February 10th. During this time, people can achieve better ... over 250,000 people from over 40 different countries as an “ordinary man with an ...
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, Inc. announced ... with the tools and information to lower the costs, and increase the impact ... of providing employee healthcare benefits by as much as 22%:, + Price ...
(Date:2/6/2016)... ... 06, 2016 , ... Shark Finds and Kevin Harrington, along with ... DRTV campaign with Belly Bands. , Having a dog is great—except when it wets ... and find nothing works, get Belly Bands, the easiest way to stop dogs ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... DUBLIN , Feb. 8, 2016 /PRNewswire/ ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ... has announced the addition of the ... - Global Forecasts to 2020" report ...
(Date:2/8/2016)... Pa. , Feb. 8, 2016  Unilife Corporation ("Unilife" ... and supplier of injectable drug delivery systems, today announced that ... six months ended December 31, 2015 after market close on ... scheduled a conference call to discuss these financial results.    ... Unilife Corporation --> About Unilife Corporation ...
(Date:2/8/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... the U.S. Food and Drug Administration (FDA) has ... for SB-318, a single treatment strategy intended to ... (MPS I). The SB-318 IND application is now ... 1/2 clinical study (SB-318-1502) designed to assess the ...
Breaking Medicine Technology: